
All Posts
How to Transition an AAV Gene Therapy Program from Adherent to Suspension Culture Safely
Transitioning an AAV gene therapy program from adherent cell culture to a suspension platform is

Transitioning an AAV gene therapy program from adherent cell culture to a suspension platform is

Grant Writing · Pharma & Drug Development · Complete Guide The Complete Guide

BOSTON, MA — May 6, 2026 — DES Pharma, a premier provider of strategic advisory

The countdown has officially begun. From May 11–14, 2026, the global biopharmaceutical community will descend

Biotech is the rare industry where a single decision — a missed FDA meeting, a

The pharmaceutical landscape is evolving rapidly, and staying ahead of the curve means keeping a
Start building reliable, high-quality drug development programs today.